Market closed
Cumberland Pharmaceuticals/$CPIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Ticker
$CPIX
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
91
ISIN
US2307701092
Website
CPIX Metrics
BasicAdvanced
$70M
-
-$0.23
-0.35
-
Price and volume
Market cap
$70M
Beta
-0.35
52-week high
$7.25
52-week low
$3.78
Average daily volume
32K
Financial strength
Current ratio
1.249
Quick ratio
1.003
Long term debt to equity
35.531
Total debt to equity
36.841
Interest coverage (TTM)
-5.03%
Management effectiveness
Return on assets (TTM)
-2.70%
Return on equity (TTM)
-11.86%
Valuation
Price to revenue (TTM)
1.636
Price to book
2.46
Price to tangible book (TTM)
6.55
Price to free cash flow (TTM)
12.839
Growth
Revenue change (TTM)
5.82%
Earnings per share change (TTM)
-61.18%
3-year revenue growth (CAGR)
3.91%
3-year earnings per share growth (CAGR)
-12.36%
CPIX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cumberland Pharmaceuticals stock?
Cumberland Pharmaceuticals (CPIX) has a market cap of $70M as of May 17, 2025.
What is the P/E ratio for Cumberland Pharmaceuticals stock?
The price to earnings (P/E) ratio for Cumberland Pharmaceuticals (CPIX) stock is 0 as of May 17, 2025.
Does Cumberland Pharmaceuticals stock pay dividends?
No, Cumberland Pharmaceuticals (CPIX) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Cumberland Pharmaceuticals dividend payment date?
Cumberland Pharmaceuticals (CPIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals (CPIX) has a beta rating of -0.35. This means that it has an inverse relation to market volatility.